(Q43981559)

28 November 2017

Gabapentin attenuates superior oblique myokymia (English)

1 reference

28 November 2017

0 references

1

Robert L Tomsak

1 reference

28 November 2017

Gregory S Kosmorsky

2

1 reference

PubMed ID

11992881

28 November 2017

R John Leigh

series ordinal

3

1 reference

PubMed ID

11992881

28 November 2017

language of work or name

English

0 references

publication date

1 May 2002

1 reference

American Journal of Ophthalmology

28 November 2017

1 reference

28 November 2017

133

1 reference

28 November 2017

721-723

1 reference

28 November 2017

5

1 reference

Superior oblique myokymia. Quantitative characteristics of the eye movements in three patients

28 November 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2802%2901343-0

Vascular compression as a cause of superior oblique myokymia disclosed by thin-slice magnetic resonance imaging

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2802%2901343-0

The natural history and results of treatment of superior oblique myokymia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2802%2901343-0

A double-blind controlled study of gabapentin and baclofen as treatment for acquired nystagmus.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2802%2901343-0

Gabapentin but not vigabatrin is effective in the treatment of acquired nystagmus in multiple sclerosis: How valid is the GABAergic hypothesis?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2802%2901343-0

10.1016/S0002-9394(02)01343-0

7 January 2021

Identifiers

DOI

1 reference

28 November 2017

1 reference

PubMed ID

11992881